Clinical Trial Update: Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

A single-center randomized trial is evaluating inhaled mesenchymal stem cell-derived exosomes for post-infectious cough. The Phase 1/2 study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-infectious Cough

Drugs mentioned

• Inhaled mesenchymal stem cell-derived exosomes (mesenchymal stem cell-derived exosomes)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Post-Infectious Cough | Phase 1, Phase 2 | Status: RECRUITING